Morgan Stanley (NYSE:MS)‘s stock had its “buy” rating reissued by analysts at JPMorgan Chase & Co. in a report released on Monday.

A number of other brokerages have also recently commented on MS. Vetr cut Morgan Stanley from a “hold” rating to a “sell” rating and set a $32.18 price target on the stock. in a research report on Tuesday, November 8th. Barclays PLC upped their price target on Morgan Stanley from $32.00 to $35.00 and gave the company an “equal weight” rating in a research report on Thursday, October 20th. Guggenheim upgraded Morgan Stanley from a “neutral” rating to a “buy” rating in a research note on Thursday, October 20th. Zacks Investment Research upgraded Morgan Stanley from a “hold” rating to a “buy” rating and set a $37.00 price objective on the stock in a research note on Friday, October 21st. Finally, Sandler O’Neill lowered Morgan Stanley from a “buy” rating to a “hold” rating and set a $33.00 price objective on the stock. in a research note on Thursday, October 6th. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and fifteen have issued a buy rating to the stock. Morgan Stanley currently has a consensus rating of “Hold” and a consensus target price of $32.59.

Analyst Recommendations for Morgan Stanley (NYSE:MS)

Shares of Morgan Stanley (NYSE:MS) opened at 40.60 on Monday. The company has a 50-day moving average price of $35.45 and a 200 day moving average price of $30.45. The firm has a market capitalization of $76.04 billion, a price-to-earnings ratio of 16.32 and a beta of 1.87. Morgan Stanley has a 1-year low of $21.16 and a 1-year high of $41.20.

Morgan Stanley (NYSE:MS) last issued its quarterly earnings results on Wednesday, October 19th. The financial services provider reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.63 by $0.17. Morgan Stanley had a return on equity of 7.57% and a net margin of 14.44%. The firm had revenue of $8.91 billion for the quarter, compared to analysts’ expectations of $8.17 billion. During the same quarter in the prior year, the firm earned $0.34 EPS. The business’s revenue for the quarter was up 14.7% compared to the same quarter last year. On average, equities research analysts predict that Morgan Stanley will post $2.71 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 15th. Stockholders of record on Monday, October 31st were given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 1.97%. The ex-dividend date of this dividend was Thursday, October 27th. Morgan Stanley’s dividend payout ratio is currently 32.00%.

ILLEGAL ACTIVITY WARNING: “Morgan Stanley (MS) Rating Reiterated by JPMorgan Chase & Co.” was originally posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this report on another website, it was stolen and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2016/11/30/morgan-stanley-ms-rating-reiterated-by-jpmorgan-chase-co.html.

In other news, insider Daniel A. Simkowitz sold 60,119 shares of the stock in a transaction that occurred on Thursday, November 10th. The stock was sold at an average price of $37.56, for a total value of $2,258,069.64. Following the completion of the transaction, the insider now owns 262,784 shares of the company’s stock, valued at approximately $9,870,167.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO James A. Rosenthal sold 189,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 20th. The shares were sold at an average price of $32.85, for a total value of $6,208,650.00. Following the transaction, the chief operating officer now directly owns 372,034 shares of the company’s stock, valued at approximately $12,221,316.90. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of MS. MCF Advisors LLC raised its position in Morgan Stanley by 0.6% in the third quarter. MCF Advisors LLC now owns 4,176 shares of the financial services provider’s stock worth $134,000 after buying an additional 26 shares during the period. FineMark National Bank & Trust raised its position in Morgan Stanley by 2.0% in the second quarter. FineMark National Bank & Trust now owns 4,332 shares of the financial services provider’s stock worth $113,000 after buying an additional 84 shares during the period. First Manhattan Co. raised its position in Morgan Stanley by 2.4% in the third quarter. First Manhattan Co. now owns 4,294 shares of the financial services provider’s stock worth $137,000 after buying an additional 100 shares during the period. Buckingham Capital Management Inc. raised its position in Morgan Stanley by 0.4% in the first quarter. Buckingham Capital Management Inc. now owns 35,092 shares of the financial services provider’s stock worth $878,000 after buying an additional 138 shares during the period. Finally, Savant Capital LLC raised its position in Morgan Stanley by 1.4% in the third quarter. Savant Capital LLC now owns 10,526 shares of the financial services provider’s stock worth $337,000 after buying an additional 150 shares during the period. 83.90% of the stock is owned by institutional investors.

Morgan Stanley Company Profile

Morgan Stanley is a financial holding company. The Company is a global financial services firm that, through its subsidiaries and affiliates, advises, and originates, trades, manages and distributes capital for, governments, institutions and individuals. Its segments include Institutional Securities, Wealth Management and Investment Management.

5 Day Chart for NYSE:MS

Receive News & Stock Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related stocks with our FREE daily email newsletter.